COVID-19 treatment with lopinavir-ritonavir resulting in sick sinus syndrome: a case report.

ABSTRACT:

Background

COVID-19 infection is the most serious global public health crisis of the century. With no approved treatments against it, investigational treatments are being used despite limited safety data. Besides being at higher risk of complications of COVID-19 infection, patients with underlying cardiovascular disease are more likely to develop cardiac-related side effects of treatment. We present a case of sinus arrest with junctional escape related to lopinavir-ritonavir.

Case summary

A 67-year-old man, with underlying stable ischaemic heart disease, acquired COVID-19 infection. He had a prolonged duration of fever and cough. He subsequently developed acute respiratory distress and required intensive care unit (ICU) care. Given his severe infection, he was started on lop

SUBMITTER: Wang LY 

PROVIDER: S-EPMC7337728 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature